APEN Stock Price, Chart, Stats & News

Apollo Endosurgery, Inc.
Save
579.72M
Market cap
–
Current P/E
–
Forward P/E
APEN chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 55.20% |
Operating margin | -36.20% |
Pretax margin | -51.08% |
Net margin | -51.84% |
Effective tax rate | -1.49% |
ROA | -36.14% |
ROE | -84.92% |
D/E | 1.75x |
Interest coverage ratio | -5.96x |
APEN valuation
P/E | – |
P/S | 7.54x |
P/B | 12.47x |
P/CF | -13.00x |
P/FCF | -17.05x |
P/OCF | -13.00x |
PEG | -0.10x |
EV multiple | -18.45x |
About
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, as well as delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands.
Similar securities
Based on sector and market capitalization
Report issue











